Your browser doesn't support javascript.
loading
A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels.
Groves, Carl; Shetty, Chandrashekar; Strange, Richard C; Waldron, Julian; Ramachandran, Sudarshan.
Afiliación
  • Groves C; Department of Clinical Biochemistry, Heart of England Foundation NHS Trust, Sutton Coldfield, UK.
  • Shetty C; Department of Clinical Biochemistry, Worcestershire Acute Hospitals NHS Trust, Worcester, Worcestershire, UK.
  • Strange RC; Institute for Science and Technology in Medicine, Keele University Medical School, Stoke-on-Trent, Staffordshire, UK.
  • Waldron J; Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent, Staffordshire, UK.
  • Ramachandran S; Department of Clinical Biochemistry, Heart of England Foundation NHS Trust, Sutton Coldfield, UK.
Postgrad Med J ; 93(1098): 205-208, 2017 Apr.
Article en En | MEDLINE | ID: mdl-27531965

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Enfermedades Cardiovasculares / Ezetimiba / Inhibidores de PCSK9 / Hipercolesterolemia / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Postgrad Med J Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Enfermedades Cardiovasculares / Ezetimiba / Inhibidores de PCSK9 / Hipercolesterolemia / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Postgrad Med J Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido